Open Access

[Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1

  • Authors:
    • Jia Zhao
    • Deguang Ding
    • Ge Zhao
  • View Affiliations

  • Published online on: April 15, 2024     https://doi.org/10.3892/etm.2024.12539
  • Article Number: 251
  • Copyright : © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

June-2024
Volume 27 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao J, Ding D and Zhao G: [Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1. Exp Ther Med 27: 251, 2024
APA
Zhao, J., Ding, D., & Zhao, G. (2024). [Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1. Experimental and Therapeutic Medicine, 27, 251. https://doi.org/10.3892/etm.2024.12539
MLA
Zhao, J., Ding, D., Zhao, G."[Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1". Experimental and Therapeutic Medicine 27.6 (2024): 251.
Chicago
Zhao, J., Ding, D., Zhao, G."[Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1". Experimental and Therapeutic Medicine 27, no. 6 (2024): 251. https://doi.org/10.3892/etm.2024.12539